Calcium mediation of cyanide-induced catecholamine release: implications for neurotoxicity

Toxicol Appl Pharmacol. 1991 Sep 1;110(2):275-82. doi: 10.1016/s0041-008x(05)80010-9.

Abstract

Exposure of rat pheochromocytoma (PC12) cells to KCN (1.0-10 mM) over a 30-min period stimulated secretion of dopamine (DA) and decreased intracellular DA content. Addition of KCN (10 mM) to rat frontal cortex slices preloaded with 1-[7-3H]norepinephrine ([3H]NE) increased secretion of NE over a 10- to 30-min incubation period. In PC12 cells release of DA by KCN was nearly abolished in calcium-free media or by prior addition of diltiazem, a calcium channel antagonist. Release of [3H]NE from rat cortical slices by cyanide was only partly inhibited by diltiazem suggesting that intracellular calcium may be involved in this response. In PC12 cells KCN also produced a dose-related release of the DA precursor dihydroxyphenylalanine, without altering intracellular stores. Levels of the DA metabolite 3,4-dihydroxyphenylacetic acid (DOPAC) were enhanced at lower concentrations of KCN. These observations indicate cyanide elicits exocytotic release of neurotransmitters in a calcium-dependent manner and also show that cyanide alters catecholamine metabolism. These actions of cyanide may be important in CNS symptoms of intoxication.

MeSH terms

  • 3,4-Dihydroxyphenylacetic Acid / metabolism*
  • Adrenal Gland Neoplasms
  • Animals
  • Calcium / pharmacology
  • Calcium / physiology*
  • Cell Line
  • Cerebral Cortex / drug effects
  • Cerebral Cortex / metabolism*
  • Diltiazem / pharmacology
  • Dopamine / metabolism*
  • Egtazic Acid / pharmacology
  • In Vitro Techniques
  • Kinetics
  • Male
  • Neurotoxins*
  • Norepinephrine / metabolism*
  • Pheochromocytoma
  • Potassium Cyanide / pharmacology*
  • Rats
  • Rats, Inbred Strains

Substances

  • Neurotoxins
  • 3,4-Dihydroxyphenylacetic Acid
  • Egtazic Acid
  • Diltiazem
  • Potassium Cyanide
  • Calcium
  • Dopamine
  • Norepinephrine